Updated:
Accrete Health Partners
We created Accrete Health Partners to help align and coalesce the best digital health teams and products to add value to the lives of people everywhere.
Accrete Health Partners
We created Accrete Health Partners to help align and coalesce the best digital health teams and products to add value to the lives of people everywhere.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Cincinnati
Corporate office
Cincinnati, OH, United States
Principals
Jason Szczuka
President at Accrete Health Partners
Cyril Philip
Vice President, Digital Ventures
Mark Townsend, MD
Chief Clinical Digital Ventures Officer
Megan Jernigan
Director of Accrete Acceleration
Sector focus
Frequently asked questions
Who runs investment decisions at Accrete Health Partners?
Jason Szczuka, President, leads overall strategy and platform growth. Cyril Philip, Vice President of Digital Ventures, leads direct venture investments and co-development partnerships. Mark Townsend, MD, serves as Chief Clinical Digital Ventures Officer, partnering with clinical and operational leaders (per the firm, firm website).
How does Accrete source proprietary deal flow?
Accrete sources deals primarily by identifying digital health teams and products that align with clinical and operational priorities inside Bon Secours Mercy Health. Its acceleration pathway lets operating leaders pilot emerging solutions, creating a pipeline for deeper investment or partnership (per the firm, firm website).
Is Accrete structured as a single family office or does it operate more like a venture firm?
Accrete describes itself as the venture and innovation platform of Bon Secours Mercy Health, functioning as a captive corporate venture arm. It makes direct equity investments, accelerates co-developments, and selectively scales proven platforms, all anchored within the health system's delivery network (per the firm, firm website).
What investment stages does Accrete typically target?
Accrete targets early-stage to growth-stage digital health companies. It uses strategic venture investments for direct equity, and an acceleration pathway for pilot and co-development with early-stage companies (per the firm, firm website).
Which sectors does Accrete explicitly avoid?
Accrete has not publicly disclosed any sectors it avoids, but its portfolio and stated focus concentrate on digital health, AI/ML, data and analytics, patient engagement, and clinical workflow technologies.
How is Accrete related to Bon Secours Mercy Health?
Accrete is the venture and innovation platform wholly owned by Bon Secours Mercy Health, a large Catholic health system. Investment decisions and portfolio company validation are grounded in the system's clinical and operational capabilities (per the firm, firm website).
What is Accrete's known posture on co-investments alongside external GPs?
Accrete has not publicly stated a policy on co-investments with external GPs. Its stated model is to make direct investments and partner with portfolio companies, with examples including co-developed modules (Atalan) and strategic rounds (Hyro’s $45M round, per news coverage).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: